Home > Financial Ratios > LYKA LABS

LYKA LABS
Core EBITDA Growth

    Back to All Ratios
LYKA LABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -99.9417.46-15.17-80.40385.97

What is the latest Core EBITDA Growth ratio of LYKA LABS ?

The latest Core EBITDA Growth ratio of LYKA LABS is -99.94 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-99.94
Mar202517.46
Mar2024-15.17
Mar2023-80.40
Mar2022385.97

How is Core EBITDA Growth of LYKA LABS Trending?

Years Core EBITDA Growth % Change
Mar2026 -99.94
Negative
Mar2025 17.46
Positive
Mar2024 -15.17
Negative
Mar2023 -80.4
Negative
Mar2022 385.97 -

Other Financial Ratios of LYKA LABS


Compare Core EBITDA Growth ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹292.7 Cr -0.8% 21.5% -17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,278.0 Cr -2.5% -4.7% 15.5% Stock Analytics
DIVIS LABORATORIES ₹243,966.0 Cr -4% 8.1% 55.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.3% 0.2% 36.6% Stock Analytics
CIPLA ₹109,950.0 Cr -1.7% -6.1% -12% Stock Analytics
DR REDDYS LABORATORIES ₹95,967.4 Cr -0.2% -4.4% -10.2% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-0.8%

21.5%

-17%

SENSEX

-2.8%

-5.2%

-8.4%


You may also like the below Video Courses